Table I. Duration of control mitosis... | Rockefeller University Press

Table I.

Duration of control mitosis versus MUG

Treatment	Control	MUG
Untreated^{^a}	0.7 ± 0.1 (n = 47)	1.6 ± 1.1 (n = 43)
5 μM nocodazole^{^b}	24.3 ± 9.1 (n = 31)	10.1 ± 5.6 (n = 34)
200 μM monastrol^{^b}	15.8 ± 5.9 (n = 35)	4.5 ± 2.5 (n = 35)
200 μM monastrol + 100 nM hesperadin^{^b}	ND	1.8 ± 1.6 (n = 34)
500 nM taxol^{^b}	20.5 ± 5.3 (n = 50)	4.6 ± 3.9 (n = 43)
500 nM taxol + 100 nM hesperadin^{^b}	ND	2.6 ± 1.2 (n = 32)

Treatment	Control	MUG
Untreated^{^a}	0.7 ± 0.1 (n = 47)	1.6 ± 1.1 (n = 43)
5 μM nocodazole^{^b}	24.3 ± 9.1 (n = 31)	10.1 ± 5.6 (n = 34)
200 μM monastrol^{^b}	15.8 ± 5.9 (n = 35)	4.5 ± 2.5 (n = 35)
200 μM monastrol + 100 nM hesperadin^{^b}	ND	1.8 ± 1.6 (n = 34)
500 nM taxol^{^b}	20.5 ± 5.3 (n = 50)	4.6 ± 3.9 (n = 43)
500 nM taxol + 100 nM hesperadin^{^b}	ND	2.6 ± 1.2 (n = 32)

Time is given in hours. Error is reported as SD.

Defined as nuclear envelope breakdown to maximum furrow ingression.

Defined as nuclear envelope breakdown to first cortical telophase activity (blebbing, furrowing, etc.).